Literature DB >> 16139170

SERT and DAT availabilities under citalopram treatment in obsessive-compulsive disorder (OCD).

Oliver Pogarell1, Gabriele Poepperl, Christoph Mulert, Christine Hamann, Nikolai Sadowsky, Michael Riedel, Hans-Juergen Moeller, Ulrich Hegerl, Klaus Tatsch.   

Abstract

Serotonin and dopamine transporter (SERT, DAT) availabilities have prospectively been investigated using [123I]beta-CIT and single photon emission computed tomography in subjects with obsessive-compulsive disorder under treatment with the selective serotonin reuptake inhibitor citalopram. SERT availability decreased by a mean 36.5%, whereas DAT availability increased by about 40%. The data point at a citalopram induced modulation of both serotonergic and dopaminergic activity and support the notion of functional interactions of monoaminergic systems in the human brain.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16139170     DOI： 10.1016/j.euroneuro.2005.01.003

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN： 0924-977X            Impact factor:   4.600


  8 in total

1.  No effect of sex on ethanol intake and preference after dopamine transporter (DAT) knockdown in adult mice.

Authors:  Amine Bahi; Jean-Luc Dreyer
Journal:  Psychopharmacology (Berl)       Date:  2018-12-12       Impact factor: 4.530

2.  [123I] ADAM brainstem binding correlates with the loudness dependence of auditory evoked potentials.

Authors:  Oliver Pogarell; Walter Koch; Nadine Schaaff; Gabriele Pöpperl; Christoph Mulert; Georg Juckel; Hans-Jürgen Möller; Ulrich Hegerl; Klaus Tatsch
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-11-07       Impact factor: 5.270

3.  Mirtazapine provokes periodic leg movements during sleep in young healthy men.

Authors:  Stephany Fulda; Stefan Kloiber; Tatjana Dose; Susanne Lucae; Florian Holsboer; Ludwig Schaaf; Johannes Hennings
Journal:  Sleep       Date:  2013-05-01       Impact factor: 5.849

4.  Amisulpride-induced acute akathisia in OCD: an example of dysfunctional dopamine-serotonin interactions?

Authors:  Karen D Ersche; Paul Cumming; Kevin J Craig; Ulrich Müller; Naomi A Fineberg; Edward T Bullmore; Trevor W Robbins
Journal:  J Psychopharmacol       Date:  2011-07-11       Impact factor: 4.153

5.  Expectancy effects on serotonin and dopamine transporters during SSRI treatment of social anxiety disorder: a randomized clinical trial.

Authors:  Olof R Hjorth; Andreas Frick; Malin Gingnell; Johanna M Hoppe; Vanda Faria; Sara Hultberg; Iman Alaie; Kristoffer N T Månsson; Jörgen Rosén; Margareta Reis; Kurt Wahlstedt; My Jonasson; Mark Lubberink; Gunnar Antoni; Mats Fredrikson; Tomas Furmark
Journal:  Transl Psychiatry       Date:  2021-11-03       Impact factor: 6.222

6.  Serotonin and dopamine transporter availability in social anxiety disorder after combined treatment with escitalopram and cognitive-behavioral therapy.

Authors:  Olof Hjorth; Andreas Frick; Malin Gingnell; Jonas Engman; Johannes Björkstrand; Vanda Faria; Iman Alaie; Per Carlbring; Gerhard Andersson; My Jonasson; Mark Lubberink; Gunnar Antoni; Margareta Reis; Kurt Wahlstedt; Mats Fredrikson; Tomas Furmark
Journal:  Transl Psychiatry       Date:  2022-10-07       Impact factor: 7.989

Review 7.  From Thought to Action: How the Interplay Between Neuroscience and Phenomenology Changed Our Understanding of Obsessive-Compulsive Disorder.

Authors:  J Bernardo Barahona-Corrêa; Marta Camacho; Pedro Castro-Rodrigues; Rui Costa; Albino J Oliveira-Maia
Journal:  Front Psychol       Date:  2015-11-23

8.  Computational modelling reveals contrasting effects on reinforcement learning and cognitive flexibility in stimulant use disorder and obsessive-compulsive disorder: remediating effects of dopaminergic D2/3 receptor agents.

Authors:  Jonathan W Kanen; Karen D Ersche; Naomi A Fineberg; Trevor W Robbins; Rudolf N Cardinal
Journal:  Psychopharmacology (Berl)       Date:  2019-07-20       Impact factor: 4.530
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.